Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)
Clinical trial NCT03606590 · COMPLETED
Trial details
- NCT number
- NCT03606590
- Sponsor
- NovoCure Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2021-01-14
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.